About 35,000 people will be diagnosed with multiple myeloma in the US this year. Consider joining a MagnetisMM clinical trial, for people with both newly diagnosed and relapsed/refractory multiple myeloma.      For more details about Pfizer’s MagnetisMM clinical trials, please visit: https://bit.ly/3ZfzQOF